RHAMM peptide ILSLELMKL (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
RHAMM peptide ILSLELMKL (HLA-A*0201)

RHAMM peptide ILSLELMKL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from Receptor for hyaluronan-mediated motility (RHAMM) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: ILSLELMKL
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

CD3/CD62L/CD45RA Fab-TACS® Magnetic Microbead Starter Kit, human

CD3/CD62L/CD45RA Fab-TACS® Magnetic Microbead Starter Kit, human

IBA Lifescience
Więcej
Strep-Tactin® Magnetic Microbeads

Strep-Tactin® Magnetic Microbeads

IBA Lifescience
Więcej
EBV EBNA-3A peptide FLRGRAYGL (HLA-B*0801)

EBV EBNA-3A peptide FLRGRAYGL (HLA-B*0801)

IBA Lifescience
Więcej